GlaxoSmithKline will evaluate a treatment from Australian biotech Cann Group as companies race to be the first approved CBD product.
Brisbane Times – Business
Business
More in:Business
Business
Hailey Bieber’s ‘glazed donut’ is a $1.5 billion gamble
The new owner of Hailey Bieber’s skincare company has a strong track record of connecting ...
Business
ASX set to rise as Wall Street moves higher; $A slips
US stocks are gaining ground and financial markets worldwide are holding relatively steady as the ...
Business
In one awful decision, Albanese has revealed his do-nothing plan
If you want to govern effectively, you have to be prepared to stand up to ...